Burning Rock Biotech Limited
BNR
$9.02
$0.010.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.07M | -48.14M | -59.31M | -78.48M | -82.29M |
| Total Depreciation and Amortization | 7.14M | 7.14M | 18.21M | 18.21M | 18.21M |
| Total Amortization of Deferred Charges | 113.00K | 113.00K | 269.80K | 269.80K | 269.80K |
| Total Other Non-Cash Items | 20.44M | 33.15M | 30.37M | 47.22M | 45.36M |
| Change in Net Operating Assets | -5.08M | -5.08M | -7.22M | -7.22M | -7.22M |
| Cash from Operations | -10.45M | -12.82M | -17.69M | -20.01M | -25.67M |
| Capital Expenditure | -753.30K | -753.30K | -1.12M | -1.12M | -1.12M |
| Sale of Property, Plant, and Equipment | 217.60K | 217.60K | 11.60K | 11.60K | 11.60K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 43.20K | -78.60K | 563.80K | 427.60K | 41.00K |
| Cash from Investing | -492.60K | -614.40K | -546.90K | -683.10K | -1.07M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -72.00K | -72.00K | -6.98M | -6.98M | -6.98M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 5.07M | -40.82M | -41.82M |
| Cash from Financing | -10.00K | -10.00K | -264.10K | -6.60M | -6.74M |
| Foreign Exchange rate Adjustments | 543.50K | 509.40K | -742.30K | -419.30K | 1.28M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.41M | -12.93M | -19.24M | -27.71M | -32.21M |